Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Nephrology (Carlton). 2019 Feb;24(2):234–244. doi: 10.1111/nep.13207

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1

Figure 1

Figure 1a. Cumulative incidence of any stroke by warfarin use among older patients (≥ 65 years) undergoing dialysis with newly diagnosed atrial fibrillation

Figure 1b. Cumulative incidence of ischemic stroke by warfarin use among older patients (≥ 65 years) undergoing dialysis with newly diagnosed atrial fibrillation

Figure 1c. Cumulative incidence of major bleeding by warfarin use among older patients (≥ 65 years) undergoing dialysis with newly diagnosed atrial fibrillation

Figure 1d. Cumulative incidence of gastrointestinal bleeding by warfarin use among older patients (≥ 65 years) undergoing dialysis with newly diagnosed atrial fibrillation

Figure 1e. Cumulative incidence of all-cause mortality by warfarin use among older patients (≥ 65 years) undergoing dialysis with newly diagnosed atrial fibrillation